Advanced Molecular Imaging and Therapy

Advanced Molecular Imaging and Therapy is a Maryland-based nuclear medicine and theranostics practice focused on outpatient molecular imaging, dosimetry, and targeted radiopharmaceutical therapy for cancer patients. The clinic has concentrated on commercially available and investigational theranostic approaches, particularly for metastatic prostate cancer, neuroendocrine tumors, thyroid cancer, and lymphoma. Its model combines PET/SPECT-based diagnostic imaging with targeted radionuclide treatment and clinical trial participation. The practice also built an Imaging Biomarkers Core Lab to support translational imaging research and quantitative interpretation services. AMIT appears to have served as the founding Glen Burnie site that later became part of the broader United Theranostics network.